Home/Filings/4/0001127602-13-006115
4//SEC Filing

Pawlicki Raymond 4

Accession 0001127602-13-006115

CIK 0000875045other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 3:12 PM ET

Size

5.8 KB

Accession

0001127602-13-006115

Insider Transaction Report

Form 4
Period: 2013-02-12
Pawlicki Raymond
SVP, Chief Information Officer
Transactions
  • Award

    Restricted Stock Unit

    2013-02-12+2,7602,760 total
    Exercise: $0.00Exp: 2017-02-12Common Stock (2,760 underlying)
Footnotes (1)
  • [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).

Issuer

BIOGEN IDEC INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001547904

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 3:12 PM ET
Size
5.8 KB